BSP Pharmaceuticals S.p.A. is glad to announce its participation to the next 9th Annual High Potent Medicines Conference - EU Edition 2024 of Milan oganized by MarketsandMarkets.
This conference is the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). It converges industry leaders and regulatory professionals on a singular platform dedicated to exploring cutting-edge developments in the development, manufacturing, and safe handling of highly potent compounds.
During this event is possible to engage with real-world experiences and case studies from companies at the forefront of successful HPAPI programs, learns from challenges, uncover best practices and pioneering strategies in containment technologies, risk assessment, and occupational health and safety that are shaping the industry's approach to safety, quality control, and regulatory compliance in effective HPAPI manufacturing.
Save the Date!!! Next Wednesday, 22nd of May, our Fabio Zenobi – EHS & Toxicology Director – will present its speech: “Manufacturing of Oncological Products by a CDMO” during the Conference Day1, starting from 15:00 to 15:30 PM.
